Delivery Order SPE2DR25D1201-SPE2DR26FAKLE
- Not listed
- The Defense Logistics Agency awarded a $51,992.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 11, 2026, for the supply of NURTEC ODT 75 mg tablets (8-count units). This is a non-set-aside competitive award with an ultimate completion date of January 12, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order execution under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 7, 2026, by the Defense Logistics Agency (DLA) for the supply of NURTEC ODT 75 MG tablets in quantities of eight units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $4,740.63 and is scheduled for completion by January 8, 2026. The award represents a task order under AmerisourceBergen's parent company...
- On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $6,762.41 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units). This non-set-aside contract employs firm fixed-price pricing and is scheduled for completion by January 12, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order. The company operates as a subsidiary of Cencora, Inc., which...
- The Defense Logistics Agency awarded a $4,941.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of NURTEC ODT 75 mg tablets (8-count units). The contract, which is a non-set-aside, competitively awarded delivery order, will be fulfilled at the awardee's Conshohocken, Pennsylvania facility, with an ultimate completion date of January 12, 2026. This delivery order operates under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count packages). This competitive, non-set-aside contract is valued at $70,553.66 with firm fixed pricing and an ultimate completion date of September 29, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $4,184.82 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG Tablet 8S, a migraine treatment medication. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The ultimate completion date is January 12, 2026, and performance will take place at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $17,560.28 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). The contract, which is non-set-aside and competitively awarded, is scheduled for completion by January 2, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,281.03 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8 count) on December 16, 2025, with an ultimate completion date of December 17, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count) valued at $9,272.88 under a firm fixed-price contract with an ultimate completion date of November 10, 2025. This is a non-set-aside competitive award to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,708.58 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8 count) on December 11, 2025, with an ultimate completion date of December 12, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing Indefinite...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAKLEDelivery Order
On January 12, 2026, the Defense Logistics Agency awarded a delivery order valued at $38,284.25 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by January 13, 2026, with performance occurring at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company competes on a full and open basis for federal contracts and maintains a substantial portfolio of pharmaceutical deliveries across multiple therapeutic domains. This delivery order for NURTEC ODT, a medication used in the treatment of migraines, reflects the company's ongoing role in supplying specialized pharmaceutical products to support the Defense Health Agency and other federal healthcare systems globally through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.3k | 1/11/26 |